Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is proud to present a deep dive into Finerenone, a revolutionary pharmaceutical compound that is transforming the landscape of cardiorenal disease treatment. As a leading supplier of high-quality pharmaceutical chemicals, we are committed to shedding light on compounds that offer significant therapeutic advancements.
Finerenone, also known by its CAS number 1050477-31-0, is a non-steroidal mineralocorticoid receptor (MR) antagonist. Its primary strength lies in its highly selective action, meaning it targets the mineralocorticoid receptor with great precision while exhibiting minimal affinity for other steroid hormone receptors. This selectivity is key to its favorable safety profile, reducing the likelihood of common side effects associated with older mineralocorticoid receptor antagonists.
The finerenone mechanism of action is centered around blocking the harmful effects of aldosterone, a hormone that can contribute to inflammation, fibrosis, and organ damage in conditions like diabetic kidney disease and heart failure. By inhibiting the MR, Finerenone helps to mitigate these damaging processes, thereby protecting the heart and kidneys.
Significant advancements in understanding finerenone for diabetic kidney disease have emerged from extensive clinical research. Studies have demonstrated its efficacy in slowing the progression of kidney disease in patients with type 2 diabetes and associated kidney damage. This makes it a vital compound for those seeking to manage or prevent the severe complications of diabetes.
Furthermore, the finerenone benefits heart failure are becoming increasingly recognized. It plays a role in improving cardiovascular outcomes, reducing the risk of hospitalization and cardiovascular death in patients with heart failure, especially when co-existing with kidney disease. The research into finerenone clinical trials consistently highlights its potential to significantly improve patient quality of life and long-term prognosis.
The unique finerenone chemical properties and its established efficacy have positioned it as a crucial pharmaceutical intermediate and active pharmaceutical ingredient (API). At NINGBO INNO PHARMCHEM CO.,LTD., we understand the importance of reliable access to such high-quality compounds. We ensure that our Finerenone meets stringent purity standards, making it suitable for both research and pharmaceutical development.
For researchers and pharmaceutical companies looking to explore the therapeutic potential of Finerenone, understanding its applications and sourcing it reliably is paramount. We are dedicated to supporting your endeavors in advancing healthcare through the provision of premium chemical ingredients. If you are looking to purchase Finerenone or learn more about its applications, consider NINGBO INNO PHARMCHEM CO.,LTD. as your trusted supplier.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
